GS
IDXX icon

GAM Systematic’s Idexx Laboratories IDXX Stock Holding History

GAM Systematic’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$407K Sell
2,620
-8,081
-76% -$1.28M 0.06% 439
2017
Q2 		$1.73M Buy
10,701
+3,923
+58% +$637K 0.25% 145
2017
Q1 		$1.05M Sell
6,778
-1,204
-15% -$166K 0.21% 193
2016
Q4 		$936K Sell
7,982
-4,393
-35% -$501K 0.22% 175
2016
Q3 		$1.4M Buy
12,375
+4,322
+54% +$456K 0.29% 90
2016
Q2 		$748K Buy
8,053
+2,987
+59% +$257K 0.18% 231
2016
Q1 		$397K Buy
+5,066
New +$365K 0.1% 350

Other funds holding IDXX

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

GAM Systematic's IDXX Position: Q3 2017 in Review

GAM Systematic reduced its Idexx Laboratories (IDXX) stake by 76% in Q3 2017, selling an estimated $1.28M and leaving 2,620 shares worth $407K. The position accounts for 0.06% of the portfolio, ranked #439.

GAM Systematic first reported a position in IDXX in Q1 2016 and has held it in 7 quarters since. The position peaked at $1.73M in Q2 2017. 573 funds tracked by Wall St. Rank hold IDXX as of Q3 2017.

  • GAM Systematic held 2,620 shares of Idexx Laboratories worth $407K as of Q3 2017.
  • GAM Systematic sold 8,081 Idexx Laboratories shares in Q3 2017, an estimated $1.28M.
  • Idexx Laboratories made up 0.06% of GAM Systematic's portfolio in Q3 2017, its #439 holding.
  • GAM Systematic first reported a position in Idexx Laboratories in Q1 2016 and has held it in 7 quarters since.
  • GAM Systematic's Idexx Laboratories position peaked at $1.73M in Q2 2017.
  • 573 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.